Literature DB >> 18182415

Cannabinoids for chronic pain.

Steven P Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18182415      PMCID： PMC2213791          DOI： 10.1136/bmj.39434.444583.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review.

Authors:  F A Campbell; M R Tramèr; D Carroll; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  2001-07-07

2.  The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients.

Authors:  Steven P Cohen; Michael H Verdolin; Audrey S Chang; Connie Kurihara; Bennie J Morlando; Jianren Mao
Journal:  J Pain       Date:  2006-06       Impact factor: 5.820

3.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.

Authors:  Lynn R Webster; Rebecca M Webster
Journal:  Pain Med       Date:  2005 Nov-Dec       Impact factor: 3.750

4.  Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

Authors:  D I Abrams; C A Jay; S B Shade; H Vizoso; H Reda; S Press; M E Kelly; M C Rowbotham; K L Petersen
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

5.  Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain.

Authors:  F Benedetti; S Vighetti; M Amanzio; C Casadio; A Oliaro; B Bergamasco; G Maggi
Journal:  Pain       Date:  1998-02       Impact factor: 6.961

6.  Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.

Authors:  Kristina B Svendsen; Troels S Jensen; Flemming W Bach
Journal:  BMJ       Date:  2004-07-16

7.  Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.

Authors:  William Notcutt; Mario Price; Roy Miller; Samantha Newport; Cheryl Phillips; Susan Simmons; Cathy Sansom
Journal:  Anaesthesia       Date:  2004-05       Impact factor: 6.955

8.  Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.

Authors:  B Frank; M G Serpell; J Hughes; J N S Matthews; D Kapur
Journal:  BMJ       Date:  2008-01-08

9.  Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

Authors:  John Zajicek; Patrick Fox; Hilary Sanders; David Wright; Jane Vickery; Andrew Nunn; Alan Thompson
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321
  9 in total
  2 in total

1.  Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec.

Authors:  Huguette St-Amant; Mark A Ware; Nancy Julien; Anaïs Lacasse
Journal:  CMAJ Open       Date:  2015-04-02

Review 2.  U.S. Policy Responses to Calls for the Medical Use of Cannabis.

Authors:  Wayne Hall
Journal:  Yale J Biol Med       Date:  2015-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.